Objective:To analyze and evaluate the implementation of clinical pathway for neonatal respiratory distress syndrome(NRDS). Methods:Children who diagnosed as NRDS in the Children Hospital of Chongqing Medical University were enrolled.Children enrolled from January 1

2013 to December 30

2014 and received clinical pathway management were taken as pathway management group;children enrolled from January 1

2011 to December 30

2012 but did not receive clinical pathway management were taken as non-pathway management group. The hospitalization expenses

length of hospital stay

respirator using time

incidence of ventilator associated pneumonia(VAP)

hospital infection and the satisfaction of children ’s parents were evaluated between two groups

and the variation of clinical pathway was analyzed. Results:There were 1 074 eligible cases in total

including 494 cases for clinical pathway management group and 580 cases for non-pathway management. There was no significant difference in age

gender

gestational age

birth weight

chest radiograph classification between two groups(P>0.05). Hospital cost

length of hospital stay and respirator using time were decreased after pathway management

besides occurrence of ventilator associated pneumonia was reduced.But there were no significant difference in hospital infection and the satisfaction of children’s parents between two groups(P>0.05).A total of 159 patients completed the clinical pathway

and variation was found in 315 cases. The main reason for variation was complications of NRDS(patent ductus arteriosus is the most common complications). Conclusion:For neonates with NRDS

clinical pathway management can reduce the length and expenses of hospitalization

as well as guarantee the efficacy and satisfaction of children’s parents. But it still needs improvement due to complications of NRDS and high variation rate.